XY0YX37 – Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
PCS Table
|
Section
X
New Technology
|
|||
|
Body System
Y
Extracorporeal
|
|||
|
Operation
0
Introduction
|
|||
| Body Part | Approach | Device / Substance / Technology | Qualifier |
|
V
Vein Graft
|
X
External
|
8
Endothelial Damage Inhibitor
|
3
New Technology Group 3
|
|
Y
Extracorporeal
|
X
External
|
3
Nafamostat Anticoagulant
|
7
New Technology Group 7
|